Home > Drug Search >
  • Targets: Gap junction protein (GJ)
  •   > 
Drug Filter
Status:
Approved (2) Phase Ⅲ (1) Phase Ⅱ (12) Phase Ⅰ (6)
Clinical Stage:
Pending (2) Active (3) Discontinued (14)
Company:
Daiichi Sankyo (2) GlaxoSmithKline (2) Johnson & Johnson (1) Novartis (1) Pfizer (1) Sanofi (1) Zydus cadila (1) Unknown (2) MEI Pharma (1) CymaBay Therapeutics (1) Inspyr Therapeutics (1) Zealand Pharma (1) Upsher-Smith Laboratories (1) Arena Pharmaceuticals (2) Astellas (1) AstraZeneca (1) Boehringer Ingelheim (1) Bristol-Myers Squibb (1)
Indication:
Alzheimer's disease (AD) (1) Atrial fibrillation (1) Chronic obstructive pulmonary disease (COPD) (1) Dyslipidemia (1) Epilepsy/Seizures (1) Glioblastoma multiforme (1) Hepatocellular carcinoma (HCC) (1) Melanoma (1) Migraine (1) Myocardial infarction (MI) (1) Obesity (1) Ovarian cancer (1) Prostate cancer (1) Type 2 diabetes (8) Stroke (1) Diabetes (1) Malaria (2) Acute ischemic stroke (AIS) (1) Thrombosis (1) Ventricular tachycardia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top